A related limitation is the overlap with HHT in clinical features; it is possible that a few patients initially diagnosed as “atypical HHT” in the past were actually CM-AVM2 before EPHB4 was discovered. This evidence concerns the gene EPHB4 and cutaneous mastocytosis.